Concepedia

Eric Padron

EP

Statistics

Publications

137

Citations

9.3K

H-Index

48

Active since

2003

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

Cleveland Clinic

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Eric Padron is an author at Moffitt Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2003–2025

137

Publications

137

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Kelly L. Bolton, Ryan Ptashkin, Teng Gao et al. · Nature Genetics · 2020 · 741 citations · Full text

, , +16

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

Michael Seiler, Akihide Yoshimi, Rachel Darman et al. · Nature Medicine · 2018 · 510 citations · Full text

, , +15

Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic Syndromes

David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Journal of Clinical Oncology · 2021 · 460 citations · Full text

, , +5

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

Ashley A. Basiorka, Kathy L. McGraw, Erika A. Eksioglu et al. · Blood · 2016 · 346 citations · Full text

, , +14

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

Nancy Gillis, Markus Ball, Qing Zhang et al. · The Lancet Oncology · 2016 · 313 citations · Full text

, , +16

1–5 of 137